A Canadian Federal Court decision (July 9, 2018) is a victory not only for Dr. Peter Doshi who filed a suit to gain access to pharmaceutical data, against the Attorney General of Canada; it is a victory for “open access” and affirmation . . . Continue reading →
This is a developing news story focusing on the corruption of industry-initiated government vaccination policies. The case involves Sanofi and the launching of its Dengvaxia vaccine in a massive school-based Dengvaxia vaccination campaign in 830,000 Philippino school children. The New York Times . . . Continue reading →
“A foolish faith in authority is the worst enemy of the truth” — Albert Einstein The wisdom of this observation is borne out by empirical evidence demonstrating that so-called “authoritative” sources of medical information are thoroughly corrupted not only by industry manipulation but . . . Continue reading →
FDA documents obtained under the Freedom of Information Act, revealed that the FDA has been concealing from the medical community and the public serious research misconduct; including fraud, deception, avoidable risks for human subjects — even deaths — that occurred in clinical . . . Continue reading →
An article in STAT News (Nov. 22) suggests that the FDA’s drug approval process and reliance on the “gold standard”will undergo “a seismic shift” in the Donald Trump administration. “Public health advocates are bracing for a seismic shift: a surrender of the agency’s rules . . . Continue reading →
The corruption of nutrition science goes back 50 years when the sugar industry bribed Harvard scientist Public health and nutrition policies that are claimed to be “science-based” are most often shaped by industry-paid academic scientists who deliver findings favorable to their corporate . . . Continue reading →
A battle is in full swing between scientists demanding access to clinical trial data from published reports; journal gatekeepers protect the interests of sponsors — commercial companies, academic institutions and government agencies. In numerous legal procedures, the claimed clinical trial results in . . . Continue reading →
A book review by AHRP board member, John J Noble Jr, Emeritus Professor, was recently published in the Indian Journal of Medical Ethics. The book, Reducing Adverse Events in Older Patients Taking Newly Released Drugs by Margaret T. Whitstock, an Australian research professional, . . . Continue reading →
Professor Peter Gøtzsche, a leading researcher who heads the Nordic Cochrane Centre, the Scandinavian arm of the Collaboration, a center for independent researchers who analyze published medical research reports and freely disseminate their findings. It should be noted that as a doctor . . . Continue reading →
Carl Elliott, MD, who has the moral gumption to stand up and speak out against “the toads and bullies who preside over academic medical centers” — including his own institution’s deplorable, but profitable human experiments in psychiatry — is especially revolted by . . . Continue reading →
The difficulty of identifying academic experts who have not crossed over to the commercially funded research was acknowledged by Dr. Marcia Angell, just before she relinquished her position as editor of The New England Journal of Medicine (“Is Academic Medicine for Sale?” . . . Continue reading →
The case against Andrew Wakefield was funded by Murdoch; hatched by Brian Deer; launched in the Sunday Times; magnified by the BMJ Brian Deer is a freelance reporter who was paid by the Rupert Murdoch’s Sunday Times to “find something big about . . . Continue reading →